<DOC>
	<DOCNO>NCT00844909</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability body affect drug CNTO 136 healthy Japanese Caucasian volunteer .</brief_summary>
	<brief_title>A Study Safety How Body Effects Drug CNTO 136 Healthy Male Japanese Caucasian Volunteers</brief_title>
	<detailed_description>This randomize , placebo-controlled , double-blinded study ass safety pharmacokinetics CNTO 136 . In randomized trial , study medication ( CNTO 136 placebo ) assign chance . Double-blinded mean neither investigator volunteer know study medication assign receive . Pharmacokinetics study level CNTO 136 circulate blood time . The study population male consist 30 Japanese 30 Caucasian volunteer . Three dose level study agent assess . Participants require stay research center study agent administration inpatient portion study require return out-patient visit . One 3 dose level CNTO 136 give skin ( subcutaneous ( SC ) ) . The length study 20 week .</detailed_description>
	<criteria>Demonstrate understanding study sign inform consent form Healthy clinically relevant abnormality determine medical history , physical examination , blood chemistry assessment , hematologic assessment include complete blood count ( CBC ) , coagulation test , urinalysis , measurement vital sign , ECG Japanese volunteer must bear Japan , reside outside Japan 5 year , Japanese parent maternal paternal grandparent . Caucasian subject must Caucasian parent Have weight range 60 kg 90 kg ( inclusive ) , body mass index ( BMI ) 19 kg/m2 29 kg/m2 Nonsmoker agree smoke 10 cigarette 2 cigar per day throughout study . Currently , history , disease dysfunction pulmonary , cardiovascular , endocrine , hematologic , neurological , immune , gastrointestinal , genitourinary , body system , clinically significant opinion investigator Have underlie physical psychological medical condition , opinion investigator , would make unlikely healthy volunteer complete study Have evidence chronic medical condition require prescription medication ( eg , hypertension , elevate cholesterol/triglycerides , asthma , diabetes ) Currently know malignancy history malignancy Have major traumatic surgery within 12 week screen surgery within 1 week .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>CNTO 136</keyword>
	<keyword>safety</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>healthy Japanese</keyword>
	<keyword>healthy Caucasian</keyword>
	<keyword>Phase I</keyword>
	<keyword>antibody</keyword>
	<keyword>male .</keyword>
</DOC>